Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Activity of Telavancin against Staphylococci and Enterococci Determined by MIC and Resistance Selection Studies
Antimicrobial Agents and Chemotherapy, 10/02/09
Kosowska–Shick K et al. – No cross–resistance was found with any clone/antimicrobial combination. The two enterococci developed resistance to daptomycin, and one developed resistance to linezolid. Single–step mutation frequencies for telavancin were lower than the spontaneous mutation frequencies obtained with the comparators.
Related Articles
Telavancin for injection (Vibativ): Lipoglycopeptide antibiotic approved for the treatment of complicated skin and skin-structure infections
Formulary, 11/02/09
Relevance Score: 87%
Telavancin: A Novel Lipoglycopeptide
Clinical Infectious Diseases, 11/16/09
Relevance Score: 83%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison between concentrations of amphotericin B in infected lung lesion and in uninfected lung tissue in a patient treated with liposomal amphotericin B
International Journal of Infectious Diseases, 12/04/09
Oral ondansetron for reducing vomiting secondary to acute gastroenteritis in children – a double-blind randomized study
Alimentary Pharmacology and Therapeutics, 12/04/09
Early and Late Direct Costs in a Southern African Antiretroviral Treatment Programme: A Retrospective Cohort Analysis
PLoS Medicine, 12/04/09
Sponsor
Article Search
Sponsor


See Latest Articles


